86
90
Growth Score
-3 pts
Heat Score
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
303203
Pharos iBT is a pharma company that specializes in the development of drugs based on AI research and analysis.
- Yoon Jeong-hyuk: CEO
About the Company
Pharos iBT is a pharmaceutical company. It specializes in developing therapeutics for rare and intractable diseases. The company's proprietary AI platform is Chemverse, and it helps to discover drug targets and develop new drug candidates. The company's pipelines include 'PHI101', a candidate for the treatment of acute myeloid
leukemia (AML) and relapsed ovarian cancer, and 'PHI-201', a candidate for a KRAS-targeted anticancer drug.
